AGP Picks
View all

The European Current: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Current.

Press releases published on May 28, 2026

Save A Warrior UK completes latest Veteran Recovery Cohort as demand grows for peer-led trauma support
Three Reputable Push Pull Connector Manufacturers in China 2026: Driving Reliable Industrial Connectivity
Merwood Capital Limited Raises Over £50,000 for Cancer Research UK Following London Marathon Challenge
Hafnia Confirms Operational Improvements from Complexio AI Deployment in Q1 2026 CEO Letter
Stoneshield Capital schließt überzeichneten Opportunity Fund IV mit Hard Cap von 1,5 Milliarden Euro
Stoneshield Capital cierra el fondo Opportunity Fund IV sobresuscrito en su límite máximo de €1.500 millones
Stoneshield Capital clôture la levée de fonds de son fonds Opportunity Fund IV, sursouscrit, à son plafond de souscription de 1,5 milliard d’euros
ストーンシールド・キャピタル、オーバーサブスクリプションとなったオポチュニティ・ファンドIVを、15億ユーロ (約2780億円) の限度額到達でクローズ
סטונשילד קפיטל סוגרת את Opportunity Fund IV שזכתה לרישום יתר בסכום תקרה קשיחה של 1.5 מיליארד אירו
Stoneshield Capital, 초과 수요 속 ‘Opportunity Fund IV’ 15억 유로 규모로 최종 마감
Stoneshield Capital Menutup Dana Peluang IV Melebihi Sasaran pada Had Maksimum €1.5 Bilion
Stoneshield Capital 以 15 亿欧元硬上限完成第四期机会型基金的超额认购
Stoneshield Capital Encerra o Opportunity Fund IV, com Excesso de Subscrição, com Limite Máximo de €1,5 bilhão
Stoneshield Capital 旗下機會基金 IV 獲得超額認購,最終以 15 億歐元硬上限圓滿封閉
Aung Crown Highlights Green Manufacturing and Flexible Supply Chain Solutions at INTEX Poland 2026
Inspection Robots Market Worldwide Set to Hit $13.94 B by 2030: Allied Market Research Forecast
Cytora and Treefera partner to bring real-time, first-mile commodity intelligence to commercial insurance workflows
ABL Diagnostics Advances NGS for CMV Resistance Monitoring at SEIMC 2026
NETRIS Pharma Secures €7.25 Million in Horizon Europe Funding to Advance Phase 2b Clinical Trial in Head and Neck Cancer
Esomar appoints Patrick de Regt as Chief Executive Officer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The European Current

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.